PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and

来源 :中国药理学报(英文版) | 被引量 : 0次 | 上传用户:easyJMS
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Epithelial-mesenchymal transition(EMT)enables dissemination of neoplastic cells and onset of distal metastasis of primary tumors.However,the regulatory mechanisms of EMT by microenvironmental factors such as transforming growth factor-β(TGF-β)remain largely unresolved.Protein tyrosine phosphatase L1(PTPL1)is a non-receptor protein tyrosine phosphatase that plays a suppressive role in tumorigenesis of diverse tissues.In this study we investigated the role of PTPL1/PTPN13 in metastasis of lung cancer and the signaling pathways regulated by PTPL1 in terms of EMT of non-small cell lung cancer(NSCLC)cells.We showed that the expression of PTPL1 was significantly downregulated in cancerous tissues of 23 patients with NSCLC compared with adjacent normal tissues.PTPL1 expression was positively correlated with overall survival of NSCLC patients.Then we treated A549 cells in vitro with TGF-β1(10 ng/mL)and assessed EMT.We found that knockdown of PTPL1 enhanced the migration and invasion capabilities of A549 cells,through enhancing TGF-β1-induced EMT.In nude mice bearing A549 cell xenografts,knockdown of PTPL1 significantly promoted homing of cells and formation of tumor loci in the lungs.We further revealed that PTPL1 suppressed TGF-β-induced EMT by counteracting the activation of canonical Smad2/3 and non-canonical p38 MAPK signaling pathways.Using immunoprecipitation assay we demonstrated that PTPL1 could bind to p38 MAPK,suggesting that p38 MAPK might be a direct substrate of PTPL1.In conclusion,these results unravel novel mechanisms underlying the regulation of TGF-β signaling pathway,and have implications for prognostic assessment and targeted therapy of metastatic lung cancer.
其他文献
Group Ⅰ metabotropic glutamate receptors(mGlu1 and mGlu5)are promising targets for multiple psychiatric and neurodegenerative disorders.Understanding the subtype selectivity of mGlu1 and mGlu5 allosteric sites is essential for the rational design of novel
Proteasome inhibitors,bortezomib(BTZ),and carfilzomib(CFZ)are approved drugs for hematological malignancies,but lack anticancer activities against most solid tumors.Small cell lung cancer(SCLC)is a very aggressive neuroendocrine carcinoma of the lungs dem
Aflibercept,as a soluble decoy vascular endothelial growth factor receptor,Which has been used as a first-line monotherapy for cancers.Aflibercept often causes cardiovascular toxicities including hypertension,but the mechanisms underlying aflibercept-indu
Hemorrhagic transformation(HT)is a common serious complication of stroke after thrombolysis treatment,which limits the clinical use of tissue plasminogen activator(t-PA).Since early diagnosis and treatment for HT is important to improve the prognosis of s
Oxidative stress is intimately tied to neurodegenerative diseases,including Parkinson\'s disease and amyotrophic lateral sclerosis,and acute injuries,such as ischemic stroke and traumatic brain injury.Acid sensing ion channel 1a(ASIC1a),a proton-gated i
目的 分析阜阳市首例人感染H5N6禽流感轻症患儿流行病学特征,为做好病例诊治及防控工作提供参考.方法 调查人感染H5N6禽流感患儿发病就诊情况、密切接触者、可疑禽类及活禽市场环境情况,采集患儿及其涉及的人群、活禽和环境标本并进行流感病毒检测,应用描述性流行病学方法进行分析.结果 阜阳市1例人感染H5N6禽流感患儿为流感常规监测发现,发病约10 h服用磷酸奥司他韦,约20 h症状消失,密切接触者无感染,可疑活禽摊位环境标本检测出现H5型禽流感病毒.结论 患儿有活禽市场环境暴露史,早发现早治疗,对减轻病情,提
Voltage-gated sodium channel Nav1.7 robustly expressed in peripheral nociceptive neurons has been considered as a therapeutic target for chronic pain,but there is no selective Nav1.7 inhibitor available for therapy of chronic pain.Ralfinamide has shown an
目的 采用指数平滑法预测艾滋病新报告病例的趋势,为泸州市制定预防和控制艾滋病策略提供依据.方法 根据2018-2019年泸州市每月艾滋病新报告病例资料,使用指数平滑法构建预测模型,预测2020年上半年每月新报告病例,并对预测结果进行评价.结果 综合比较指数平滑法四种模型的判断指标,确定Holt线性趋势模型为最优预测模型,模型的拟合度较高,实际值均在预测值的95%置信区间内.2020年1~6月艾滋病新报告病例数和模型预测值的平均相对误差33.19%.结论 Holt线性趋势模型可较好地拟合泸州市艾滋病新报告病
Acute liver failure(ALF)is a fatal clinical syndrome with no special drug.Recent evidence shows that modulation of macrophage to inhibit inflammation may be a promising strategy for ALF treatment.In this study we investigated the potential therapeutic eff
Brexpiprazole(Bre)is a new multi-target antipsychotic drug(APD)approved by the US FDA in 2015,and shows good therapeutic potential.But it lacks assessments on the metabolic side effects,which obstructs the treatment of schizophrenia.Glucagon-like peptide